28 April 2022
Top hires for VC & PE portfolio companies Q1-2022
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location | 
|---|---|---|
| CEO | Surgical robotics | Switzerland | 
| President US | Immuno-oncology | China | 
| Chief Scientific Officer | Oncology | US | 
| Chief Medical Officer | Regenerative medicine | US | 
| Chief Medical Officer | Oncology and gastrointestinal diseases | China | 
| Chief Commercial Officer | DNA-based diagnostics | Sweden | 
| Chief Operating Officer | Oncology | US | 
| Chief Financial Officer | AI-enabled femtech | Ireland | 
| Head of Chemistry | Precision therapeutics | UK | 
| Head of Sales Americas | AI-enabled diagnostics | Nordics | 
| VP Clinical Development | Precision biotherapeutics | Singapore | 
| VP General Manager Pharma Services | Molecular diagnostics | US | 
| VP Marketing & Communications | Rapid diagnostics | Belgium | 
| Chair | RNA-based therapeutics | Germany | 
| Chair | Drug discovery services | UK | 
| Partner | Transatlantic life sciences investor | UK | 
Newly opened projects include:
| Function | Focus area | Location | 
|---|---|---|
| CEO | Immuno-oncology | Belgium | 
| Chief Development Officer | Novel gene therapies | Spain | 
| Chief Medical Officer | Age-related diseases | US | 
| Chief Medical Officer | Digital therapeutics | Sweden | 
| Chief Scientific Officer | Cell therapies | US | 
| Chief Commercial Officer | Clinical research organisation | US | 
| VP Business Development & Strategy | AI for drug discovery | China | 
| Head of Medicinal Chemistry | Discovery tools | UK | 
| Head of CMC | Bispecific antibodies & oncology | Switzerland | 
| Head of Biology | Radiopharmaceuticals | Germany | 
| Commercial Head Europe | Cloud-based neuro-diagnostics | Nordics | 
| Director Global Remote Care | Medical devices | France | 
| Chair | Oncology | Finland/ US | 
| Board Director | Gene therapies | Netherlands | 
Related
- 
                                
    
    
Events
AESC Global Summit on Leadership
17 November 2025 – 18 November 2025
 - 
                                
    
    
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
         - 
                                
    
    
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
 - 
                                
    
    
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023